Cargando…
HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma
PURPOSE: Osteosarcoma (OS) is the most common bone cancer with a high risk of metastasis, high growth rate, and poor prognosis. Honokiol (HNK) is a general ingredient of traditional Chinese medicine, with a potential anti-tumor effect. However, HNK is insoluble in water and lacks drug targeting, whi...
Autores principales: | Zhang, Xiangxiang, Chen, Huaen, Zhang, Yang, Huang, Qijing, Feng, Jianjia, Xing, Haoyu, Fu, Xiaguo, Yan, Xiufang, Zhang, Yingying, Xu, Qin, Liang, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636865/ https://www.ncbi.nlm.nih.gov/pubmed/36345507 http://dx.doi.org/10.2147/IJN.S371934 |
Ejemplares similares
-
Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis
por: Li, Xin, et al.
Publicado: (2023) -
Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization
por: Li, Shenglan, et al.
Publicado: (2021) -
Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model
por: Jiang, Qi-qi, et al.
Publicado: (2008) -
Erratum to liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization
Publicado: (2023) -
Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways
por: Yang, Jianhong, et al.
Publicado: (2016)